Hansoh Pharma (翰森制药) Post-IPO Trading Update: Fairly Valued
Hansoh Pharma's IPO was priced at the high end and started trading last Friday. In our earlier note, we argued that the company should trade at...
549 Views
ECM Weekly (15 Jun 2019) - Budweiser Brewing Co, Jinxin Fertility, Wanda Sports, Hansoh Pharma
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
577 Views
Last Week in GER Research: ESR Cayman, Hansoh Pharma, China East Education and Tencent
Below is a recap of the key IPO and fundamental research produced by the Global Equity Research team. This week we update on the valuation for...
684 Views
ECM Weekly (8 Jun 2019) -ESR Cayman, Shanghai Henlius, Edvantage, JH Education
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
678 Views
Hansoh Pharma IPO: Valuation Reasonable for the Trade-Offs
Hansoh Pharmaceutical (3692 HK) claims to be one of the few R&D driven Chinese pharmaceutical companies. It announced its IPO price range of...
716 Views